Thank you for moving science forward.
Your dedication over 60 days helped us better understand ProleevaMax. Here is what we learned together about pain, fatigue and inflammation—in plain language.
See what we learned ↓A small group with big commitment.
Adults living with ongoing pain took ProleevaMax at home for about two months. You were your own comparison—we measured each person at the start and again at the end.
enrolled
took at least one dose
completed the study
of doses taken on average
The 60-day arc.
Baseline
Welcome, first blood test & surveys.
At home
ProleevaMax + wearable tracking, every day.
Momentum
Check-in surveys—early shifts in energy.
Impact
Final blood test & surveys.
Three things worth taking home.
“Meaningful” = at least a 3-point change on the standard PROMIS questionnaire score.
Most people felt better.
On average, pain intensity, pain interference and fatigue all improved—and the changes were large and very unlikely to be due to chance.
Your blood and your answers agreed.
A blood test and a questionnaire measure health in completely different ways. People whose inflammation dropped were also the ones who reported feeling less pain and fatigue.
Two independent measures pointing the same way strengthens the signal.
Steady and reassuring.
No concerning changes were reported during the 60-day trial. The supplement was well-tolerated by the 27 participants who completed the study.
- Everyone took ProleevaMax and knew it—there was no placebo group.
- People who start with very high values naturally tend to come down a bit on re-testing.
- None of this erases the signal—it tells us what the next study needs to control for.